Choreo LLC’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$839K Buy
17,744
+2,128
+14% +$109K 0.01% 729
2026
Q1
$926K Buy
15,616
+588
+4% +$38.1K 0.01% 643
2025
Q4
$935K Buy
15,028
+1,151
+8% +$70.5K 0.01% 634
2025
Q3
$866K Sell
13,877
-646
-4% -$45K 0.01% 663
2025
Q2
$1.16M Buy
14,523
+4,050
+39% +$339K 0.02% 535
2025
Q1
$900K Sell
10,473
-3,627
-26% -$298K 0.01% 592
2024
Q4
$1.09M Buy
14,100
+3,249
+30% +$252K 0.02% 543
2024
Q3
$769K Buy
10,851
+865
+9% +$61.3K 0.01% 686
2024
Q2
$677K Buy
+9,986
New +$677K 0.01% 677

Other funds holding PBH

Choreo LLC's PBH Position: Q2 2026 in Review

Choreo LLC increased its Prestige Consumer Healthcare (PBH) stake by 14% in Q2 2026, buying an estimated $109K and bringing the position to 17,744 shares worth $839K. The position accounts for 0.01% of the portfolio, ranked #729.

Choreo LLC first reported a position in PBH in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.16M in Q2 2025. 318 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Choreo LLC held 17,744 shares of Prestige Consumer Healthcare worth $839K as of Q2 2026.
  • Choreo LLC bought 2,128 Prestige Consumer Healthcare shares in Q2 2026, an estimated $109K.
  • Prestige Consumer Healthcare made up 0.01% of Choreo LLC's portfolio in Q2 2026, its #729 holding.
  • Choreo LLC first reported a position in Prestige Consumer Healthcare in Q2 2024 and has held it in 9 quarters since.
  • Choreo LLC's Prestige Consumer Healthcare position peaked at $1.16M in Q2 2025.
  • 318 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.